Local Institution - 0095

Madrid 28050

1 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma (HCC), Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) — Recruiting now
• A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery — Completed